IRCT20201004048919N1尚未招募3 期
Mirtazapine Augmentation in Resistant Obsessive Compulsive Disorder:a Double Blind Placebo Controlled Clinical Trial
适应症
试验速览
- 阶段
- 3 期
- 状态
- 尚未招募
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •people who have been diagnosed with obsessive -compulsive disorder based on DSM5.
- •People with a yale-brown obsessive compulsive scale above 15.
- •Has an age range of 18 to 60 years.
排除标准
- •Pregnant women and breastfeeding
- •People receivinig psychotherapy.
- •having major physical illnesse: liver problems (they have high liver enzymes),kidney problems(BUN ,CR are high), thyroid problem, trouble breathing.
- •They have other psychiatric problems: According to the DSM5 criteria, they have psychotic disorder, anxiety disorder, dementia, mood disorder, and mental retardation.
- •use drugs or alcohol
研究者
相似试验
进行中（未招募）
1 期
A randomised placebo controlled trial in which mirtazapine, an antidepressant, is added for patients with depression in primary care who have not responded to treatment with first-line antidepressants.Treatment resistant depressionMedDRA version: 16.0Level: LLTClassification code 10045543Term: Unipolar depressionSystem Organ Class: 100000004873EUCTR2012-000090-23-GBniversity of Bristol470
已完成
不适用
Mirtazapine augmentation enhances cognitive and negative symptoms in schizophrenic patients treated with risperidone: a randomised controlled trialSchizophreniaISRCTN54975957Bundang CHA Hospital (South Korea)25
尚未招募
Unknown
Aripiprazole augmentation for obsessive-compulsive symptoms of major depressive disorderKCT0009595Chung-Ang Univerisity Hospital60
尚未招募
Unknown
A comparative clinical experiment of mirtazapine and amitriptyline in India on patients with recurring symptoms of an upset stomach that have no obvious causeCTRI/2024/01/061596Indian Council of Medical Research (ICMR)
尚未招募
不适用
The Soltab Understanding Patient Preferences in ORal Therapy (SUPPORT) surveydepressionMental Health - DepressionACTRN12607000310460Adrenalin Strategics1,600